Shanghai Pharmaceuticals Holding Co Ltdis A Leading Chinese Pharmaceutical Company Based In Shanghaiae S Pilot Free Trade Zoneestablished In 1994It Operates As A Dual Listed Entity On The Shanghai And Hong Kong Stock Exchangesthe Company Ranks Among Chinaae S Largest Pharmaceutical Firms And Is Recognized As A Global Fortune 500 Company Shanghai Pharma Generated $36 8 Billion In Revenue In 2023 And Employs Over 48 000 Peopleit Operates Through Four Main Segmentsproductiondistributionretailand Othersthe Company Focuses On The Research And Development Of Treatments For Various Health Conditionsincluding Cardiovascular Diseasesmetabolic Disordersautoimmune Conditionsinfectious Diseasesand Neurological And Respiratory Disordersits Product Portfolio Includes Both Chemical Drugs And Traditional Chinese Medicinesshanghai Pharma Serves Healthcare Providersretail Consumersand Manufacturersemphasizing Domestic Market Penetration While Expanding In The Asia Pacific Region
